Golimumab's Efficacy in Patients with Very Active Disease in Methotrexate-naive Rheumatoid Arthritis

被引:0
|
作者
Emery, Paul [1 ,2 ]
Fleischmann, R. M. [3 ,4 ]
Hsia, Elizabeth C. [5 ]
Xu, Stephen
Xu, Weichun [6 ]
Baker, Daniel G. [5 ]
机构
[1] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
[2] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Metroplex Clin Res Ctr, Dallas, TX USA
[5] Centocor R&D, Malvern, PA USA
[6] Centocor R&D, Malvern, PA USA
来源
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1210
引用
收藏
页码:S470 / S471
页数:2
相关论文
共 50 条
  • [41] LACK OF EARLY CHANGE IN DISEASE ACTIVITY SCORE PREDICTS THE LIKELIHOOD OF ACHIEVING LOW DISEASE ACTIVITY AT MONTH 6: TOFACITINIB MONOTHERAPY VERSUS METHOTREXATE IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Keystone, E.
    van Vollenhoven, R. F.
    Wilkinson, B.
    Fallon, L.
    Hwang, L. -J.
    Chapman, D.
    DeMasi, R.
    Lee, E. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 250 - 250
  • [42] EFFICACY AND SAFETY OF ADD-ON GOLIMUMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING CONCOMITANT METHOTREXATE OR LEFLUNOMIDE
    Wollenhaupt, J.
    Alonso-Ruiz, A.
    Spieler, W.
    Beier, J.
    Molina, J.
    Yao, R.
    Govoni, M.
    Vastesaeger, N.
    Weng, H. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 869 - 870
  • [43] Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study
    Tanaka, Yoshiya
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Miyasaka, Nobuyuki
    Koike, Takao
    Kanazawa, Minoru
    Oba, Takuya
    Yoshinari, Toru
    Baker, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 817 - 824
  • [44] Exposure-efficacy assessment of golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: Application of population pharmacokinetic/pharmacodynamic modeling
    Zhou, H.
    Xu, Z.
    Rahman, M. U.
    Wagner, C.
    Pendley, C.
    Han, J.
    Baker, D.
    Jang, H.
    Davis, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 514 - 514
  • [45] A Systematic Review and Network Meta-Analysis on the Efficacy of Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy Versus Triple Therapy in Methotrexate-Naive Patients with Rheumatoid Arthritis
    Fleischmann, Roy
    Pope, Janet E.
    Tongbram, Vanita
    Tang, Derek
    Chung, James
    Collier, David
    Urs, Shilpa
    Ndirangu, Kerigo
    Wells, George A.
    van Vollenhoven, Ronald F.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] COST AND COST PER RESPONDER IN SPAIN OF ADALIMUMAB, METHOTREXATE AND APREMILAST IN THE TREATMENT OF METHOTREXATE-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS
    Morell, A.
    Ramirez, E.
    Llorente, I
    Garcia-Vicuna, R.
    Blasco, A. J.
    VALUE IN HEALTH, 2016, 19 (07) : A540 - A540
  • [47] Maintenance of Efficacy and Safety with Subcutaneous Golimumab Among Patients with Active Rheumatoid Arthritis Who Previously Received Intravenous Golimumab
    Taylor, Peter C.
    Ritchlin, Christopher
    Mendelsohn, Alan
    Baker, Daniel
    Kim, Lilianne
    Xu, Zhenhua
    Mack, Michael
    Kremer, Joel
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2572 - 2580
  • [48] UPADACITINIB MONOTHERAPY IMPROVES PATIENT-REPORTED OUTCOMES IN METHOTREXATE-NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM SELECT-EARLY
    Strand, Vibeke
    Tundia, Namita
    Radominski, Sebastiao
    Friedman, Alan
    Dunlap, Kendall
    Goldschmidt, Deborah
    Bergman, Martin
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 372 - 373
  • [49] COMPREHENSIVE DISEASE CONTROL WITH GOLIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Combe, B.
    Veale, D.
    Burgos-Vargas, R.
    Szucs, G.
    Leirisalo-Repo, M.
    Yao, R.
    Govoni, M.
    Vastesaeger, N.
    Weng, H. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 223 - 224
  • [50] Predictive Factors Related to the Efficacy of Golimumab in Patients with Rheumatoid Arthritis
    Kanbe, Katsuaki
    Chiba, Junji
    Inoue, Yasuo
    Taguchi, Masashi
    Yabuki, Akiko
    CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2015, 8 : 25 - 32